CYPH · Market closed
$3.43
-13.16% today·exchange n/a
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
Top Premarket Gainers
MT Newswires · 31d ago
Winklevoss-Backed Cypherpunk Launches 'World's Largest' Zcash Mining Fleet
decrypt · 36d ago
Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research
PR Newswire · 43d ago
Headlines from Yahoo Finance. Not investment advice.